Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis

被引:27
作者
Buergy, Daniel [1 ]
Wuerschmidt, Florian [2 ]
Gkika, Eleni [3 ]
Hoerner-Rieber, Juliane [4 ]
Knippen, Stefan [5 ,6 ]
Gerum, Sabine [7 ,8 ]
Balermpas, Panagiotis [9 ]
Henkenberens, Christoph [10 ]
Voglhuber, Theresa [11 ]
Kornhuber, Christine [12 ]
Barczyk, Steffen [13 ]
Roeper, Barbara [14 ]
Rashid, Ali [15 ]
Blanck, Oliver [16 ]
Wittig, Andrea [5 ]
Herold, Hans-Ulrich [17 ]
Brunner, Thomas B. [18 ]
Klement, Rainer J. [11 ,19 ]
Kahl, Klaus Henning [20 ]
Ciernik, Ilja F. [21 ]
Ottinger, Annette [22 ]
Izaguirre, Victor [12 ]
Putz, Florian [6 ]
Koenig, Laila [4 ]
Hoffmann, Michael [23 ]
Combs, Stephanie E. [24 ,25 ]
Guckenberger, Matthias [11 ]
Boda-Heggemann, Judit [1 ]
机构
[1] Heidelberg Univ, Klin Strahlentherapie & Radioonkol, Med Fak Mannheim, Univ Med Mannheim, Mannheim, Germany
[2] Radiol Allianz, Strahlentherapie, Hamburg, Germany
[3] Univ Klinikum Freiburg, Strahlenheilkunde, Freiburg, Germany
[4] Univ Klinikum Heidelberg, Klin Radioonkol & Strahlentherapie, Heidelberg, Germany
[5] Univ Klinikum Jena, Klin Strahlentherapie & Radioonkol, Jena, Germany
[6] Univ Klinikum Erlangen, Strahlenklin, Erlangen, Germany
[7] Radioonkol LMU Munchen, Strahlentherapie & Radioonkol, Munich, Germany
[8] Paracelsus Univ Salzburg, Klin Radiotherapie & Radioonkol, Salzburg, Austria
[9] Univ Zurich, Universitatsspital Zurich, Klin Radioonkol, Zurich, Switzerland
[10] Hannover Med Sch, Klin Strahlentherapie & Spezielle Onkol, Hannover, Germany
[11] Tech Univ Munchen TUM, Dept Radiat Oncol, Munich, Germany
[12] Univ Klinikum Halle Saale, Halle, Saale, Germany
[13] St Agnes Hosp, Belegklin, Zentrum Strahlentherapie & Radioonkol, Bocholt, Germany
[14] Gemeinschaftspraxis Strahlentherapie Bogenhause, Munich, Germany
[15] MediClin Robert Janker Klin, Klin Strahlentherapie & Radioonkol, Bonn, Germany
[16] Univ Klinikum Schleswig Holstein, Klin Strahlentherapie, Kiel, Germany
[17] Cyberknife Ctr Mitteldeutsch GmbH, Inst Radiochirurg & Prazisionsbestrahlung, Erfurt, Germany
[18] Univ Klinikum Magdeburg, Klin Strahlentherapie, Magdeburg, Germany
[19] Leopoldina Krankenhaus Schweinfurt, Klin Strahlentherapie, Schweinfurt, Germany
[20] Univ Klinikum Augsburg, Klin Strahlentherapie & Radioonkol, Augsburg, Germany
[21] Stadt Klinikum Dessau, Klin Strahlentherapie & Radioonkol, Dessau, Germany
[22] Klinikum Darmstadt GmbH, Inst Radioonkol & Strahlentherapie, Darmstadt, Germany
[23] Klinikum Univ Munchen, LMU, Klin & Poliklin Strahlentherapie & Radioonkol, Munich, Germany
[24] Helmholtz Zentrum Munchen HMGU, Neuherberg, Germany
[25] Deutsch Zentrum Translat Krebsforsch DKTK, Partner Site Munich, Munich, Germany
关键词
adrenal; oligometastases; outcome; patterns of care; SBRT; BODY RADIATION-THERAPY; CELL LUNG-CANCER; LOCAL CONSOLIDATIVE THERAPY; LAPAROSCOPIC ADRENALECTOMY; MAINTENANCE THERAPY; GLAND METASTASES; SBRT; PATTERNS; TESTS; LIVER;
D O I
10.1002/ijc.33546
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To report outcome (freedom from local progression [FFLP], overall survival [OS] and toxicity) after stereotactic, palliative or highly conformal fractionated (>12) radiotherapy (SBRT, Pall-RT, 3DCRT/IMRT) for adrenal metastases in a retrospective multicenter cohort within the framework of the German Society for Radiation Oncology (DEGRO). Adrenal metastases treated with SBRT (<= 12 fractions, biologically effective dose [BED10] >= 50 Gy), 3DCRT/IMRT (>12 fractions, BED10 >= 50 Gy) or Pall-RT (BED10 < 50 Gy) were eligible for this analysis. In addition to unadjusted FFLP (Kaplan-Meier/log-rank), we calculated the competing-risk-adjusted local recurrence rate (CRA-LRR). Three hundred twenty-six patients with 366 metastases were included by 21 centers (median follow-up: 11.7 months). Treatment was SBRT, 3DCRT/IMRT and Pall-RT in 260, 27 and 79 cases, respectively. Most frequent primary tumors were non-small-cell lung cancer (NSCLC; 52.5%), SCLC (16.3%) and melanoma (6.7%). Unadjusted FFLP was higher after SBRT vs Pall-RT (P = .026) while numerical differences in CRA-LRR between groups did not reach statistical significance (1-year CRA-LRR: 13.8%, 17.4% and 27.7%). OS was longer after SBRT vs other groups (P < .05) and increased in patients with locally controlled metastases in a landmark analysis (P < .0001). Toxicity was mostly mild; notably, four cases of adrenal insufficiency occurred, two of which were likely caused by immunotherapy or tumor progression. Radiotherapy for adrenal metastases was associated with a mild toxicity profile in all groups and a favorable 1-year CRA-LRR after SBRT or 3DCRT/IMRT. One-year FFLP was associated with longer OS. Dose-response analyses for the dataset are underway.
引用
收藏
页码:358 / 370
页数:13
相关论文
共 48 条
[11]   A retrospective review of CyberKnife stereotactic body radiotherapy for adrenal tumors (primary and metastatic): Winthrop University Hospital experience [J].
Desai, Amishi ;
Rai, Hema ;
Haas, Jonathan ;
Witten, Matthew ;
Blacksburg, Seth ;
Schneider, Jeffrey G. .
FRONTIERS IN ONCOLOGY, 2015, 5
[12]   Choice and interpretation of statistical tests used when competing risks are present [J].
Dignam, James J. ;
Kocherginsky, Maria N. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) :4027-4034
[13]   Laparoscopic adrenalectomy for isolated adrenal metastasis: The right thing to do and the right way to do it [J].
Duh, Quan-Yang .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (12) :3288-3289
[14]   Competing risks in survival data analysis [J].
Dutz, Almut ;
Loeck, Steffen .
RADIOTHERAPY AND ONCOLOGY, 2019, 130 :185-189
[15]   Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery [J].
Franzese, Ciro ;
Franceschini, Davide ;
Cozzi, Luca ;
D'Agostino, Giuseppe ;
Comito, Tiziana ;
De Rose, Fiorenza ;
Navarria, Pierina ;
Mancosu, Pietro ;
Tomatis, Stefano ;
Fogliata, Antonella ;
Scorsetti, Marta .
CANCER RESEARCH AND TREATMENT, 2017, 49 (01) :20-28
[16]   Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study [J].
Gomez, Daniel R. ;
Tang, Chad ;
Zhang, Jianjun ;
Blumenschein, George R., Jr. ;
Hernandez, Mike ;
Lee, J. Jack ;
Ye, Rong ;
Palma, David A. ;
Louie, Alexander, V ;
Camidge, D. Ross ;
Doebele, Robert C. ;
Skoulidis, Ferdinandos ;
Gaspar, Laurie E. ;
Welsh, James W. ;
Gibbons, Don L. ;
Karam, Jose A. ;
Kavanagh, Brian D. ;
Tsao, Anne S. ;
Sepesi, Boris ;
Swisher, Stephen G. ;
Heymach, John, V .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (18) :1558-1565
[17]   Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study [J].
Gomez, Daniel R. ;
Blumenschein, George R., Jr. ;
Lee, J. Jack ;
Hernandez, Mike ;
Ye, Rong ;
Camidge, D. Ross ;
Doebele, Robert C. ;
Skoulidis, Ferdinandos ;
Gaspar, Laurie E. ;
Gibbons, Don L. ;
Karam, Jose A. ;
Kavanagh, Brian D. ;
Tang, Chad ;
Komaki, Ritsuko ;
Louie, Alexander V. ;
Palma, David A. ;
Tsao, Anne S. ;
Sepesi, Boris ;
William, William N. ;
Zhang, Jianjun ;
Shi, Qiuling ;
Wang, Xin Shelley ;
Swisher, Stephen G. ;
Heymach, John V. .
LANCET ONCOLOGY, 2016, 17 (12) :1672-1682
[18]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[19]   Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery [J].
Guckenberger, Matthias ;
Baus, Wolfgang W. ;
Blanck, Oliver ;
Combs, Stephanie E. ;
Debus, Juergen ;
Engenhart-Cabillic, Rita ;
Gauer, Tobias ;
Grosu, Anca L. ;
Schmitt, Daniela ;
Tanadini-Lang, Stephanie ;
Moustakis, Christos .
STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (05) :417-420
[20]   OLIGOMETASTASES [J].
HELLMAN, S ;
WEICHSELBAUM, RR .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :8-10